Xenon Pharmaceuticals Inc.
XENE · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$234 | -$182 | -$125 | -$79 |
| Dep. & Amort. | $3 | $4 | $2 | $1 |
| Deferred Tax | -$9 | -$0 | -$0 | $0 |
| Stock-Based Comp. | $51 | $32 | $20 | $10 |
| Change in WC | $6 | $6 | -$1 | -$3 |
| Other Non-Cash | $3 | -$4 | $6 | $1 |
| Operating Cash Flow | -$181 | -$145 | -$98 | -$70 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$3 | -$6 | -$3 | -$2 |
| Net Acquisitions | $0 | $0 | $296 | -$145 |
| Inv. Purchases | -$532 | -$794 | -$551 | -$389 |
| Inv. Sales/Matur. | $700 | $682 | $258 | $145 |
| Other Inv. Act. | $0 | $0 | -$296 | $145 |
| Investing Cash Flow | $165 | -$117 | -$296 | -$247 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $12 | $353 | $278 | $447 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $1 | $0 |
| Financing Cash Flow | $12 | $354 | $278 | $448 |
| Forex Effect | -$2 | $0 | -$2 | -$1 |
| Net Chg. in Cash | -$6 | $91 | -$118 | $131 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $149 | $57 | $176 | $45 |
| End Cash | $143 | $149 | $57 | $176 |
| Free Cash Flow | -$184 | -$151 | -$101 | -$72 |